The global Acinetobacter pneumonia therapeutics market is estimated...

adicionou um novo artigo Health

2024-04-25 13:25:31

The global Acinetobacter pneumonia therapeutics market is estimated to driven by pipeline candidates

The emergence of multi-drug resistant Acinetobacter strains has created an urgent medical need for the development of novel therapeutics targeting this pathogen. Currently, treatment options are extremely limited due to multidrug resistance. The global Acinetobacter pneumonia therapeutics market is estimated to be valued at US$ 614.9 million in 2024 and is expected to exhibit a CAGR of 5.8%...

0 Comentários 0 Compartilhamentos 380 Visualizações